BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38669537)

  • 1. Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer's Disease.
    Butler T; Wang X; Chiang G; Xi K; Niogi S; Glodzik L; Li Y; Razlighi QR; Zhou L; Hojjati SH; Ozsahin I; Mao X; Maloney T; Tanzi E; Rahmouni N; Tissot C; Lussier F; Shah S; Shungu D; Gupta A; De Leon M; Mozley PD; Pascoal TA; Rosa-Neto P
    J Alzheimers Dis; 2024; 99(1):307-319. PubMed ID: 38669537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein.
    Ji B; Ono M; Yamasaki T; Fujinaga M; Zhang MR; Seki C; Aoki I; Kito S; Sawada M; Suhara T; Sahara N; Higuchi M
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2076-2089. PubMed ID: 33557690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.
    Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C
    Neuroimage; 2011 Jun; 56(3):1111-21. PubMed ID: 21320609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
    Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
    J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
    Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
    Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update.
    Gouilly D; Saint-Aubert L; Ribeiro MJ; Salabert AS; Tauber C; Péran P; Arlicot N; Pariente J; Payoux P
    Eur J Neurosci; 2022 Mar; 55(5):1322-1343. PubMed ID: 35083791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mitochondrial protein TSPO in Alzheimer's disease: relation to the severity of AD pathology and the neuroinflammatory environment.
    Garland EF; Dennett O; Lau LC; Chatelet DS; Bottlaender M; Nicoll JAR; Boche D
    J Neuroinflammation; 2023 Aug; 20(1):186. PubMed ID: 37580767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein.
    Lyoo CH; Ikawa M; Liow JS; Zoghbi SS; Morse CL; Pike VW; Fujita M; Innis RB; Kreisl WC
    J Nucl Med; 2015 May; 56(5):701-6. PubMed ID: 25766898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
    Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
    Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains.
    Xu J; Sun J; Perrin RJ; Mach RH; Bales KR; Morris JC; Benzinger TLS; Holtzman DM
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1423-1434. PubMed ID: 31402620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation.
    Biechele G; Blume T; Deussing M; Zott B; Shi Y; Xiang X; Franzmeier N; Kleinberger G; Peters F; Ochs K; Focke C; Sacher C; Wind K; Schmidt C; Lindner S; Gildehaus FJ; Eckenweber F; Beyer L; von Ungern-Sternberg B; Bartenstein P; Baumann K; Dorostkar MM; Rominger A; Cumming P; Willem M; Adelsberger H; Herms J; Brendel M
    Theranostics; 2021; 11(18):8964-8976. PubMed ID: 34522221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains.
    Gui Y; Marks JD; Das S; Hyman BT; Serrano-Pozo A
    Brain Pathol; 2020 Jan; 30(1):151-164. PubMed ID: 31276244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytic TSPO Upregulation Appears Before Microglial TSPO in Alzheimer's Disease.
    Tournier BB; Tsartsalis S; Ceyzériat K; Fraser BH; Grégoire MC; Kövari E; Millet P
    J Alzheimers Dis; 2020; 77(3):1043-1056. PubMed ID: 32804124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.
    Kreisl WC; Lyoo CH; McGwier M; Snow J; Jenko KJ; Kimura N; Corona W; Morse CL; Zoghbi SS; Pike VW; McMahon FJ; Turner RS; Innis RB;
    Brain; 2013 Jul; 136(Pt 7):2228-38. PubMed ID: 23775979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model.
    Rossano SM; Johnson AS; Smith A; Ziaggi G; Roetman A; Guzman D; Okafor A; Klein J; Tomljanovic Z; Stern Y; Brickman AM; Lee S; Kreisl WC; Lao P
    Alzheimers Dement; 2024 Apr; 20(4):2397-2407. PubMed ID: 38298155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of Microglial Activation in Alzheimer's Disease by [
    Donat CK; Mirzaei N; Tang SP; Edison P; Sastre M
    Methods Mol Biol; 2018; 1750():323-339. PubMed ID: 29512083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects.
    Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein.
    Gershen LD; Zanotti-Fregonara P; Dustin IH; Liow JS; Hirvonen J; Kreisl WC; Jenko KJ; Inati SK; Fujita M; Morse CL; Brouwer C; Hong JS; Pike VW; Zoghbi SS; Innis RB; Theodore WH
    JAMA Neurol; 2015 Aug; 72(8):882-8. PubMed ID: 26052981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial Activation and Connectivity in Alzheimer Disease and Aging.
    Rauchmann BS; Brendel M; Franzmeier N; Trappmann L; Zaganjori M; Ersoezlue E; Morenas-Rodriguez E; Guersel S; Burow L; Kurz C; Haeckert J; Tatò M; Utecht J; Papazov B; Pogarell O; Janowitz D; Buerger K; Ewers M; Palleis C; Weidinger E; Biechele G; Schuster S; Finze A; Eckenweber F; Rupprecht R; Rominger A; Goldhardt O; Grimmer T; Keeser D; Stoecklein S; Dietrich O; Bartenstein P; Levin J; Höglinger G; Perneczky R
    Ann Neurol; 2022 Nov; 92(5):768-781. PubMed ID: 36053756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.